QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) Vaccine
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Paclitaxel
Related studies linked through entity extraction aliases.
T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Study on Drug Sensitivity Verification or Prediction of Therapy for Breast Cancer by Patient-Derived Organoid Model
- Status
- UNKNOWN
- Phase
- NA
Study on MK-3475 Plus Chemotherapy Versus Chemotherapy Alone in Recurrent, Platinum-resistant Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Ketogenic Diet and Chemotherapy in Affecting Recurrence in Patients With Stage IV Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Induction Chemotherapy Followed by Standard Therapy in Cervical Cancer With Aortic Lymph Node Spread
- Status
- RECRUITING
- Phase
- PHASE3
Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775])
- Status
- COMPLETED
- Phase
- PHASE3
Paclitaxel-Avelumab for Angiosarcoma
- Status
- UNKNOWN
- Phase
- PHASE2
Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Carboplatin, Paclitaxel With or Without Avelumab in Advanced or Recurrent Endometrial Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE3
A Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary Site
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
N-acetyl Cysteine Effect in Peripheral Neuropathy in Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Effects of Rifampin on Pharmacokinetics (PK) of Pevonedistat in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites
- Status
- UNKNOWN
- Phase
- PHASE3
A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)
- Status
- COMPLETED
- Phase
- PHASE3
Study on Decitabine Plus Carboplatin Versus Physician's Choice Chemotherapy in Recurrent, Platinum-resistant Ovarian Cancer.
- Status
- UNKNOWN
- Phase
- PHASE2